TRPV1 and breast cancer: In addition, 5-iodoresiniferatoxin (I-RTX), a selective natural antagonist of TRPV1 32 also reduced BCIBP (Fig. 2G) and down-regulated pERK1/2 and pCREB expression in DRGs of 4T1 BC mice (Fig. 2H).